A. Christopher MacIe M.D.

A. Christopher Macie, MD, MBA has a diverse work experience in various medical affairs roles. A. Christopher is currently serving as the Senior Director of Medical Affairs at HEMA Biologics, where they are responsible for the introduction and support of SEVENFACT, a treatment for Hemophilia A or B patients with inhibitors. In this leadership role, they shape and defines the strategies and tactics for medical affairs product pipeline, launch, and post-marketing commitments.

Before joining HEMA Biologics, Dr. Macie worked as the Director of Medical Affairs at Saol Therapeutics from 2019 to 2020, where they played a crucial role in medical affairs activities. Prior to that, they served as the Medical Director of Neurology at UCB from 2018 to 2019. A. Christopher also had experience working as a Field Medical Affairs professional at DBV Technologies from 2017 to 2018.

Dr. Macie had a significant tenure at Novo Nordisk. From 2010 to 2016, they held the position of Executive Director of Biopharmaceuticals, where they were responsible for developing and executing strategies for the field-based medical teams and enhancing relationships with key thought leaders and payors. During this time, they recruited, developed, led, and expanded the Medical Science Liaison group at Novo Nordisk.

Prior to Novo Nordisk, they worked at Sanofi-aventis Pharmaceuticals as an Area Medical Officer from 2008 to 2010. In this role, they coordinated medical affairs activities and ensured strategic medical direction aligned with the company's business strategy. Before that, they served as an Executive Director at Novo Nordisk Inc. from 2003 to 2008, where they led the field-based Regional Scientific Affairs team with a focus on diabetes.

Dr. Macie's earlier work experience includes roles at Wyeth-Ayerst Pharmaceuticals as a Director of Medical Science, where they created and trained the Medical Liaison Team, and at Roche Pharmaceuticals as a Clinical Medical Liaison, where they maintained professional relationships with healthcare customers and recruited investigators for clinical research programs.

Overall, Dr. Macie's work experience showcases their expertise in medical affairs, leadership, strategy development, relationship building, and team management.

A. Christopher Macie, MD, MBA completed their Bachelor of Arts (BA) degree in History at Hobart and William Smith Colleges from 1978 to 1981. Subsequently, they attended the Universidad Autónoma de Guadalajara from 1981 to 1985, where they obtained their Doctor of Medicine (M.D.) degree in Medicine. Later, from 2002 to 2004, they pursued a Master of Business Administration (MBA) degree in Business at Regis University. Finally, in 2011 to 2013, they studied at The Wharton School, although no specific degree or field of study is mentioned.